PE69498A1 - Derivados de piridina 3-sulfonamida - Google Patents

Derivados de piridina 3-sulfonamida

Info

Publication number
PE69498A1
PE69498A1 PE1997000444A PE00044497A PE69498A1 PE 69498 A1 PE69498 A1 PE 69498A1 PE 1997000444 A PE1997000444 A PE 1997000444A PE 00044497 A PE00044497 A PE 00044497A PE 69498 A1 PE69498 A1 PE 69498A1
Authority
PE
Peru
Prior art keywords
compounds
cycle
preference
react
alkyl
Prior art date
Application number
PE1997000444A
Other languages
English (en)
Inventor
Derek Edward Brundish
Lyndon Nigel Brown
Grand Darren Mark Le
Keith Allan Menear
Garrick Paul Smith
Mark Christopher Allen
Paul Ian Butler
Xiao-Ling Cockroft
Ian Timothy William Matthews
Clive Victor Walker
William Bernard Wathey
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PE69498A1 publication Critical patent/PE69498A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE REFIEREN A COMPUESTOS DE FORMULA (I), EN DONDE: "A" Y R ESTAN AUSENTES o "A" ES UN GRUPO METILENO O ETILENO; R ES H, HALOGENO, AZIDA, OR9, NR10R11; R9 ES H, ALQUILO O HIDROXIALQUILO; R10 Y R11 SON H, ALQUILO O JUNTO CON EL ATOMO DE N FORMAN UN CICLO; m ES 0; 1 o 2; n ES 1; 2 o 3; R1 ES DE PREFERENCIA FENILO OPCIONALMENTE SUSTITUIDO CON UNO MAS 0R4, SR5 o NR6R7; R2 ES UN DERIVADO DE AMINOACIDO, TAL COMO FENILALANINA, TIROSINA O DOPA, ENTRE OTROS; SIENDO R2-CH2 DE PREFERENCIA 4-METILAMINOBENCILO, 2-BENZOTIAZOLILMETILO O 4-HIDROXIBENCILO, ENTRE OTROS; R3 PRESENTA 2 o 3 ATOMOS DE CARBONO Y SE ENCUENTRA OPCIONALMENTE SUSTITUIDO POR OH, F O Cl; R4, R5, R6 Y R7 SON H, ALQUILO O HETEROCICLO MONO O BICICLICO, ENTRE OTROS; EN LOS COMPUESTOS EXISTEN Y SE PREFIEREN 2 CENTROS ASIMETRICOS DE CONFIGURACIONES (S). TAMBIEN SE REFIERE AL PROCEDIMIENTO DE PREPARACION DE LOS COMPUESTOS DE FORMULA (I), QUE COMPRENDE: 1. REACCIONAR 4-CLOROPIRIDINA-3-SULFONILCLORURO CON X-CO-CH(CH2-R2)-NH2, EN DONDE "X" ES OH, OPCIONALMENTE PROTEGIDO, 2. REACCIONAR LO OBTENIDO EN (1) CON R1(CH2)m-CH(NH2)-A-R, 3. REACCIONAR LO OBTENIDO EN (2) CON UNA BASE DE AMINA CICLICA. LOS COMPUESTOS OBTENIDOS ACTUAN COMO INHIBIDORES POTENTES DE LAS PROTEASAS DE SERINA (TROMBINA), TIENEN BUENA BIODISPONIBILIDAD Y SON USADOS EN EL TRATAMIENTO DE TROMBOSIS DE VENA, ENTRE OTROS
PE1997000444A 1996-06-01 1997-05-29 Derivados de piridina 3-sulfonamida PE69498A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9611461.6A GB9611461D0 (en) 1996-06-01 1996-06-01 New compounds

Publications (1)

Publication Number Publication Date
PE69498A1 true PE69498A1 (es) 1998-11-27

Family

ID=10794610

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1997000444A PE69498A1 (es) 1996-06-01 1997-05-29 Derivados de piridina 3-sulfonamida

Country Status (8)

Country Link
AR (1) AR008376A1 (es)
AU (1) AU2908197A (es)
CO (1) CO4940504A1 (es)
GB (1) GB9611461D0 (es)
ID (1) ID16990A (es)
PE (1) PE69498A1 (es)
WO (1) WO1997046553A1 (es)
ZA (1) ZA974779B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2003137766A (ru) * 2001-06-12 2005-05-20 Ск Корпорейшн (Kr) Новые фенилалкильные аналоги диаминов и амидов
EP1425029A4 (en) * 2001-08-10 2006-06-07 Palatin Technologies Inc PEPTIDOMIMETICS OF BIOLOGICALLY ACTIVE METALLOPEPTIDES
GB0507577D0 (en) 2005-04-14 2005-05-18 Novartis Ag Organic compounds
WO2009142984A1 (en) * 2008-05-22 2009-11-26 Boehringer Ingelheim International Gmbh Alpha-substituted n-sulfonyl gylcine amides antagonists of ccr10, compositions containing the same and methods for using them
US20140066431A1 (en) 2010-11-15 2014-03-06 Exelixis, Inc. Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture
EP2643316A2 (en) 2010-11-24 2013-10-02 Exelixis, Inc. Benzoxazepines as inhibitors of p13k/mtor and methods of their use and manufacture
CN112679448B (zh) * 2020-12-31 2022-08-19 苏州昊帆生物股份有限公司 N-(2-氨基乙基)吗啉的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH31294A (en) * 1992-02-13 1998-07-06 Thomae Gmbh Dr K Benzimidazolyl derivatives, pharmaceutical compositions containing these compounds and process for preparing them.
US5648368A (en) * 1992-12-01 1997-07-15 Merck & Co., Inc. Fibrinogen receptor antagonists
FR2727413B1 (fr) * 1994-11-25 1996-12-20 Synthelabo Derives de 5-(1h-imidazol-4-yl)-1-oxo-2-(phenylsulfonamino)- pentylpiperidine, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
ID16990A (id) 1997-11-27
AU2908197A (en) 1998-01-05
ZA974779B (en) 1997-12-01
CO4940504A1 (es) 2000-07-24
AR008376A1 (es) 2000-01-19
GB9611461D0 (en) 1996-08-07
WO1997046553A1 (en) 1997-12-11

Similar Documents

Publication Publication Date Title
PA8539401A1 (es) Quinazolinas como inhibidores de mmp-13
BG105969A (en) Amine derivatives as protein inhibitors
EA200100971A1 (ru) Новые соединения и композиции в качестве ингибиторов протеазы
BG66094B1 (bg) Азабициклени съединения, тяхното получаване и използване като лекарствени средста, по-специално като антибактериални средства
ES2213831T3 (es) Inhibidores de cisteina-proteasa.
EA200100994A1 (ru) 1-АМИНОТРИАЗОЛО[4,3-а]ХИНАЗОЛИН-5-ОНЫ И/ИЛИ -5-ТИОНЫ, ИНГИБИРУЮЩИЕ ФОСФОДИЭСТЕРАЗУ-IV
EA200600513A1 (ru) Бициклические [3.1.0] производные в качестве ингибиторов переносчиков глицина
BG66085B1 (bg) Фенилаланинови производни
EA200300527A1 (ru) Новые способы лечения синдрома "усталых ног"
AR007828A1 (es) Compuestos derivados de piridilpirrol, procedimiento de preparacion y composiciones farmaceuticas conteniendo los mismos
NO20060703L (no) Fremgangsmate for fremstilling av cis-4-fluor-1-prolinderivater
NO985518D0 (no) Morfinanderivater og medisinsk anvendelse derav
PT1736157E (pt) Derivados de morfinano como agentes anti-prurido
PT822934E (pt) Derivados de amidinotetra-hidro-piridilalanina antitromboticos
MY133445A (en) 2-arylethyl-(piperidin-4-ylmethyl)amine derivetives
PE69498A1 (es) Derivados de piridina 3-sulfonamida
PE20040594A1 (es) Derivados de isoquinolina
EA200301203A1 (ru) Новые соединения и композиции как ингибиторы катепсина
DE69427517D1 (de) Tetracyclische kondensierte heterocyclische Verbindungen zur Behandlung von seniler Demenz
MXPA04000443A (es) Metodo novedoso para la sintesis de derivados del acido (2s, 3as, 7as)-1-[(s)-alanil]-octahidro-1h-indol-2-carboxilico y la aplicacion en la sintesis de perindopril.
PA8563601A1 (es) Acidos-3-(imidazolil)-2- alcoxipropanoicos
PE20050336A1 (es) Compuestos triciclicos como inhibidores de la proteina farnesil transferasa
MY125037A (en) 1,2,3,4 tetrahydroquinoline derivatives
HK1040237A1 (en) Fused polycyclic amino acids as pharmaceutical agents.
EA200200807A1 (ru) Аминокислотные соединения и их применение в качестве ингибиторов nep, ace и ece

Legal Events

Date Code Title Description
FA Abandonment or withdrawal